DK2380979T3 - Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling - Google Patents

Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling

Info

Publication number
DK2380979T3
DK2380979T3 DK09834882.4T DK09834882T DK2380979T3 DK 2380979 T3 DK2380979 T3 DK 2380979T3 DK 09834882 T DK09834882 T DK 09834882T DK 2380979 T3 DK2380979 T3 DK 2380979T3
Authority
DK
Denmark
Prior art keywords
protein
preparation
triple helix
helix structure
triple
Prior art date
Application number
DK09834882.4T
Other languages
English (en)
Inventor
Keiichi Yamamoto
Yuzuru Kitahara
Yusuke Suzuki
Hiroshi Tahara
Yasuhiko Suzuki
Original Assignee
Univ Hokkaido Nat Univ Corp
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hokkaido Nat Univ Corp, Fuso Pharmaceutical Ind filed Critical Univ Hokkaido Nat Univ Corp
Application granted granted Critical
Publication of DK2380979T3 publication Critical patent/DK2380979T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK09834882.4T 2008-12-22 2009-12-22 Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling DK2380979T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008325691 2008-12-22
PCT/JP2009/071327 WO2010074081A1 (ja) 2008-12-22 2009-12-22 三重螺旋構造を有するタンパク質、およびその製造方法

Publications (1)

Publication Number Publication Date
DK2380979T3 true DK2380979T3 (da) 2015-06-22

Family

ID=42287689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09834882.4T DK2380979T3 (da) 2008-12-22 2009-12-22 Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling

Country Status (12)

Country Link
US (1) US8470555B2 (da)
EP (1) EP2380979B1 (da)
JP (1) JP5645187B2 (da)
KR (1) KR101686688B1 (da)
CN (2) CN106243229B (da)
AU (1) AU2009331327B2 (da)
CA (1) CA2748015C (da)
DK (1) DK2380979T3 (da)
ES (1) ES2536198T3 (da)
HK (1) HK1163153A1 (da)
PT (1) PT2380979E (da)
WO (1) WO2010074081A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101655492B1 (ko) 2008-12-22 2016-09-07 국립대학법인 홋가이도 다이가쿠 동물세포를 사용해서 외래유전자 유래 단백질을 대량으로 생산하기 위한 발현 벡터, 및 그의 이용
CA2787376A1 (en) 2010-01-19 2011-07-28 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
SG10201608671SA (en) 2011-07-18 2016-12-29 Harvard College Engineered Microbe-Targeting Molecules and Uses Thereof
CN102351954B (zh) * 2011-10-26 2013-12-18 陕西巨子生物技术有限公司 重组胶原蛋白
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof
CA3012006A1 (en) * 2017-07-31 2019-01-31 Modern Meadow, Inc. Yeast strains and methods for controlling hydroxylation of recombinant collagen
EP4225353A1 (en) * 2020-10-08 2023-08-16 Jellatech, Inc. Produce, isolate and/or extract collagen and/or gelatin from animal cell lines and/or tissue explants

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8708009D0 (en) 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
WO1993007889A1 (en) 1991-10-23 1993-04-29 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant dna systems
US5428022A (en) 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
GB9409768D0 (en) 1994-05-16 1994-07-06 Medical Res Council Trimerising polypeptides
JPH0823979A (ja) 1994-07-15 1996-01-30 Terumo Corp ヒト・コラーゲン発現ベクターおよびヒト・コラーゲンの製造方法
CA2400143C (en) 1995-08-17 2009-05-12 Fuso Pharmaceutical Industries, Ltd. Recombinant conglutinin and producing method thereof
KR100633221B1 (ko) * 1998-08-24 2006-10-11 후소 야쿠힝 고교 가부시끼가이샤 신규 콜렉틴
JP2001316282A (ja) 2000-05-11 2001-11-13 Yoshihiko Shimizu 生理活性ペプチド含有コラーゲン成形体及びその製法
JP3603103B2 (ja) 2000-11-15 2004-12-22 独立行政法人農業・生物系特定産業技術研究機構 動物（但し、ヒトを除く。）の受精卵の共培養担体及びこの担体を用いる動物（但し、ヒトを除く。）の受精卵の培養方法
US20040043034A1 (en) * 2000-11-27 2004-03-04 Jensenius Jens Christian Collectins as adjuvants
JP2002325584A (ja) 2000-11-30 2002-11-12 Japan Science & Technology Corp 組換えヒトｉｖ型コラーゲンペプチドとその製造方法
JP4701336B2 (ja) 2001-04-18 2011-06-15 独立行政法人農業生物資源研究所 ヒト・コラーゲンを産生する形質転換カイコ
EP1539964B1 (en) * 2002-09-10 2006-12-27 Natlmmune A/S Collectin-complement activating protein chimeras
JP4681214B2 (ja) 2003-06-10 2011-05-11 グンゼ株式会社 コラーゲンスポンジの製造方法及び人工皮膚の製造方法
JP2005014774A (ja) 2003-06-26 2005-01-20 Kubota Corp 作業車の車軸ケース支持構造
EP2390326B1 (en) * 2005-03-31 2014-07-09 Fuso Pharmaceutical Industries Ltd. Process of producing human type II collagen
GB2433029A (en) 2005-12-09 2007-06-13 Ethicon Inc Wound dressings comprising oxidized cellulose and human recombinant collagen
JP4677559B2 (ja) 2006-02-02 2011-04-27 財団法人ヒューマンサイエンス振興財団 任意の形状のビトリゲルと、当該ビトリゲルの製造方法
WO2007102200A1 (ja) * 2006-03-07 2007-09-13 Osaka University 抗ｃｄ２０モノクローナル抗体
CA2716766A1 (en) 2008-02-27 2009-09-03 Fuso Pharmaceutical Industries, Ltd. Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof

Also Published As

Publication number Publication date
US20120059152A1 (en) 2012-03-08
ES2536198T3 (es) 2015-05-21
EP2380979A1 (en) 2011-10-26
AU2009331327A1 (en) 2011-07-14
WO2010074081A1 (ja) 2010-07-01
CN106243229B (zh) 2019-09-06
US8470555B2 (en) 2013-06-25
JPWO2010074081A1 (ja) 2012-06-21
AU2009331327A8 (en) 2011-07-28
KR101686688B1 (ko) 2016-12-14
CN106243229A (zh) 2016-12-21
EP2380979A4 (en) 2012-07-25
CA2748015A1 (en) 2010-07-01
HK1163153A1 (en) 2012-09-07
CA2748015C (en) 2017-02-28
PT2380979E (pt) 2015-06-26
AU2009331327B2 (en) 2014-04-24
CN102325882A (zh) 2012-01-18
KR20110119650A (ko) 2011-11-02
JP5645187B2 (ja) 2014-12-24
EP2380979B1 (en) 2015-04-15

Similar Documents

Publication Publication Date Title
DK2380979T3 (da) Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling
LTPA2017035I1 (lt) Gydymas afukozintu anti-CD20 antikūnu kartu su bendamustinu
EP2419120A4 (en) HUMAN PROTEIN CONCERNS WITH CONTROLLED SERUM PHARMACOKINETICS
HK1147505A1 (en) Methods to stabilize proteins and polypeptides
DK2139987T3 (da) Fremgangsmåder til proteinfremstilling med anti-senescens-forbindelser
EP2249618A4 (en) HEATING ON BOARD OF A VEHICLE AND MANUFACTURING METHOD THEREFOR
GB201207521D0 (en) Nput/output architechture for mounted processors, and methods of using same
FI20096315A0 (fi) Menetelmä suspensiosulatusuunin käyttämiseksi ja suspensiosulatusuuni
EP2267146A4 (en) METHOD OF DEATURING PROTEIN WITH ENZYMES
GB0922209D0 (en) Proteins, nucleic acid molecules and compositions
EP2416209A4 (en) COVERING DEVICE FOR INSTRUMENT, INSTRUMENT THEREFOR AND METHOD FOR COVERING AN INSTRUMENT TO COVER DISPLAY
EP2637598A4 (en) BRIDGES AND DENTAL SUPERSTRUCTURES, AND METHODS OF MANUFACTURING THE SAME
FI20090142A0 (fi) Uudet menetelmät ja tuotteet
PL2862478T3 (pl) Szczoteczka do zębów i technologia jej produkcji
EP2410337A4 (en) PROCESS FOR BETA-GLUCAN MEASUREMENT AND BETA-GLUCAN BINDING PROTEIN FOR USE IN THIS METHOD
DE112009001910A5 (de) Sleep determination and sleep determination method
EP2273269A4 (en) METHOD FOR MANUFACTURING BIOSENSOR AND BIOSENSOR
ZA201100019B (en) Variant hhip1 protein and methods and uses thereof
IL213749A0 (en) Dgati nucleic acids and proteins and methods of use thereof
DK2192165T3 (da) Belagt forstærkning samt fremgangsmåde til dens fremstilling
EP2342481A4 (en) CANNEL PROFILE WITHOUT CONCENTRATION OF CONSTRAINTS
FI20096106A0 (fi) Menetelmä komposiittituotteen valmistamiseksi, komposiittituote ja sen käyttö
EP2319922A4 (en) NUCLEIC ACID PROBE ASSEMBLY AND METHOD OF USE
PL2252304T3 (pl) Agregaty platyny i sposób ich wytwarzania
EP2320931A4 (en) COMPOSITIONS COMPRISING MG29 NUCLEIC ACIDS, POLYPEPTIDES AND ASSOCIATED METHODS OF USE